11:23 AM EST - Avicanna Inc. : Applauds President Trump’s executive order directing the reclassification of cannabis as a less dangerous substance from Schedule I to Schedule III controlled substance while also mentioning the importance of scientific research. Avicanna is also pleased to provide a scientific update on advancements across the Company’s research and development, clinical development, and medical affairs programs. Avicanna Inc.
shares T.AVCN are trading down $0.02 at $0.22.
